If you live with asthma or COPD and also monitor your blood sugar, you may have noticed something confusing: your glucose readings sometimes rise when your breathing symptoms get worse or after certain inhaled medicines.
So, can inhalers raise blood sugar levels?
The short answer is yes, some inhaled medicines can contribute to a rise in blood glucose, but the effect depends strongly on the type of inhaler, dose, frequency of use, and your individual health. Inhaled corticosteroids generally have much less systemic effect than steroid tablets, while high doses of some bronchodilators such as salbutamol can temporarily increase blood glucose.
For people with diabetes, prediabetes, asthma, or COPD, understanding this difference can prevent unnecessary worry—and help ensure that an important respiratory medicine is not stopped without medical advice.
Medical note: This article is for health education, not individual diagnosis or treatment. If your blood glucose is repeatedly high, your breathing is worsening, or you are considering changing an inhaler, speak with your doctor or pharmacist.
1. Can Inhalers Raise Blood Sugar Levels?
Quick answer: Some inhalers can affect blood glucose, but not all inhalers have the same effect. Inhaled corticosteroids usually have limited systemic absorption at standard doses, while high-dose or frequent use may have greater systemic effects. Beta-2 agonists such as salbutamol can also cause reversible increases in blood glucose, particularly at higher doses.
An inhaler is a delivery device, not a single type of medicine. Two people may both say they are “using an inhaler,” while actually taking completely different drugs.
Common inhaled medicines include:
- Inhaled corticosteroids (ICS) – reduce airway inflammation.
- Short-acting beta-2 agonists (SABA) – provide quick bronchodilation.
- Long-acting beta-2 agonists (LABA) – keep airways open for longer.
- Long-acting muscarinic antagonists (LAMA) – provide long-lasting bronchodilation.
- Combination inhalers – contain two or more medicines.
This distinction matters because the potential effect on blood glucose varies between drug classes.
For example, salbutamol is a beta-2 agonist. Product information states that beta-2 agonists can produce reversible metabolic changes, including increased blood glucose.
Practical tip: Don’t judge an inhaler only by its brand name. Check the active ingredients and ask your healthcare professional what each component does.
2. Why Would an Inhaler Affect Blood Glucose?
Quick answer: Some respiratory medicines can influence glucose metabolism. Corticosteroids can increase glucose production and reduce insulin sensitivity, while beta-2 agonists can stimulate metabolic pathways that temporarily increase glucose levels. The effect is generally more important with higher systemic exposure.
The body carefully balances glucose through hormones such as insulin. Certain medicines can temporarily change this balance.
Corticosteroids
Steroids can increase glucose production by the liver and make the body’s tissues less sensitive to insulin. This is why oral or injectable corticosteroids are well known to cause hyperglycemia.
However, inhaled corticosteroids are delivered primarily to the lungs and generally produce much less systemic exposure than oral steroids.
The amount that reaches the bloodstream depends on factors such as:
- Dose
- Drug potency
- Inhaler/device type
- Lung absorption
- How much medicine is swallowed
- Liver metabolism
- Duration of treatment
GINA notes that systemic effects of inhaled corticosteroids depend on dose, potency, delivery system, systemic bioavailability, and metabolism.
Beta-2 agonists
Medicines such as salbutamol work differently. They stimulate beta-2 receptors to relax airway muscles.
At higher doses, beta-2 agonists can also affect metabolism and increase blood glucose. Product information for inhaled salbutamol specifically advises caution in people with diabetes because blood glucose can rise.
Example: A person having a severe asthma attack may receive repeated or high-dose salbutamol. Their glucose may temporarily increase, but this does not necessarily mean the inhaler has caused permanent worsening of diabetes.
3. Do Steroid Inhalers Cause Diabetes?
Quick answer: Standard-dose inhaled corticosteroids are not considered equivalent to steroid tablets in their effect on blood sugar. Evidence about long-term glucose effects is mixed, with greater concern at higher doses and in people who already have diabetes or other metabolic risk factors.
This is one of the most important distinctions in the topic.
A person may hear that “steroids raise blood sugar” and assume every steroid inhaler will cause diabetes. That conclusion is too broad.
Inhaled corticosteroids are designed to deliver medication directly to the airways, limiting exposure elsewhere in the body.
GINA’s patient information states that long-term corticosteroid tablets can provoke diabetes, whereas inhaled corticosteroids have not been shown to have the same effect in asthma.
At the same time, researchers have investigated whether prolonged or high-dose ICS treatment might contribute to diabetes risk, particularly among people with COPD. Some observational research has reported associations, while the overall evidence remains complicated by factors such as disease severity, steroid exposure and other health conditions.
A systematic review of systemic effects of inhaled corticosteroids in asthma found limited and conflicting evidence and noted that many studies had important limitations.
Practical takeaway: Don’t stop an ICS inhaler because you are worried about diabetes. Ask whether your current dose is appropriate and whether your blood glucose needs monitoring.
4. What About Salbutamol and Other Reliever Inhalers?
Quick answer: Salbutamol and other beta-2 agonists can cause a temporary increase in blood glucose, especially with higher doses or repeated treatment. This effect is generally reversible, but people with diabetes may need closer glucose monitoring during intensive treatment.
Salbutamol—also known as albuterol in some countries—is commonly used as a rapid bronchodilator.
It relaxes airway muscles and can make breathing easier during bronchospasm.
But beta-2 stimulation can also influence metabolism.
Official medicine information describes possible increases in blood glucose with salbutamol and notes that people with diabetes may have difficulty compensating for this rise.
The effect is particularly relevant when:
- Large doses are used
- Nebulized treatment is given repeatedly
- The patient is having a severe asthma attack
- Diabetes is poorly controlled
- Corticosteroids are being used at the same time
Importantly, a glucose rise after a reliever inhaler does not mean you should avoid the medicine during an asthma attack.
Breathing comes first.
If your reliever is required much more frequently than usual, the underlying respiratory disease may not be adequately controlled and should be medically reviewed.
5. Asthma, Inhalers and Blood Sugar: What Is the Connection?
Quick answer: Asthma itself and the medicines used during worsening asthma can both influence glucose readings. In particular, severe attacks may require high doses of bronchodilators and sometimes systemic corticosteroids, both of which can contribute to hyperglycemia.
Imagine someone with asthma and type 2 diabetes.
Their asthma becomes worse. They begin using their reliever more frequently. Their doctor may then prescribe a short course of oral corticosteroids if clinically appropriate.
Now their blood glucose rises.
Which medicine caused it?
It may not be one single factor.
Possible contributors include:
| Factor | Possible effect on glucose |
|---|---|
| Standard-dose ICS | Usually limited systemic glucose effect |
| High-dose/long-term ICS | May have greater systemic effects |
| Salbutamol/beta-2 agonist | Can temporarily increase glucose |
| Oral corticosteroids | Stronger and well-established effect |
| Severe illness/stress | Can independently increase glucose |
| Reduced physical activity | May worsen glucose control |
This is why a healthcare professional needs to consider the whole clinical picture, rather than blaming every glucose change on an inhaler.
GINA emphasizes the importance of effective inhaled treatment for controlling asthma and reducing severe exacerbations.
6. What About COPD and Blood Sugar?
Quick answer: People with COPD can experience glucose problems for several reasons, including underlying metabolic disease, acute illness, systemic corticosteroid treatment and, in some cases, long-term inhaled corticosteroid exposure. COPD treatment decisions should therefore consider both respiratory benefits and metabolic risks.
COPD is different from asthma, although some medicines overlap.
In COPD, inhaled corticosteroids may be prescribed for selected patients, often as part of combination therapy. They are not automatically appropriate for every person with COPD.
The 2025 GOLD report provides evidence-based recommendations for COPD diagnosis and management and emphasizes selecting treatment according to individual patient characteristics and exacerbation risk.
Research has identified a possible association between inhaled corticosteroid exposure and diabetes development or worsening glycemic control in COPD, particularly in observational studies. However, this does not mean every COPD patient using an ICS will develop diabetes.
There is another important issue: COPD exacerbations themselves can be associated with poor glucose control.
One study found that elevated blood glucose was associated with a higher risk of subsequent severe COPD exacerbation, although this does not establish that inhalers caused the elevated glucose.
7. Inhaled Steroids vs Oral Steroids: Which Has More Effect on Blood Sugar?
Quick answer: Oral corticosteroids generally have a much stronger systemic effect on blood glucose than standard-dose inhaled corticosteroids because a greater amount of the drug reaches the bloodstream. Inhaled steroids can still have systemic effects, particularly at high doses or with prolonged treatment.
This is an important comparison for patients who have diabetes.
| Feature | Inhaled corticosteroids | Oral corticosteroids |
|---|---|---|
| Main delivery | Airways/lungs | Whole body |
| Systemic exposure | Generally lower | Much higher |
| Blood glucose effect | Usually limited at standard doses | Common and clinically important |
| Long-term systemic effects | Dose-dependent | More established |
| Monitoring in diabetes | May be appropriate depending on risk | Often important |
NHS guidance explains that steroid tablets can increase blood glucose, while inhaled steroids are unlikely to do so in most people.
That does not mean inhaled corticosteroids have zero systemic absorption.
Rather, the degree of exposure is usually much smaller.
This is one reason doctors try to use the lowest inhaled corticosteroid dose that effectively controls asthma, while still maintaining appropriate disease control. GINA notes that high-dose ICS is needed by relatively few patients and that long-term high-dose use carries greater systemic side-effect risk.
8. Can High Blood Sugar Make Asthma or COPD Worse?
Quick answer: High blood glucose does not simply “cause” every asthma or COPD flare, but poor metabolic control can be associated with worse outcomes, particularly in COPD. Illness, inflammation, reduced activity and steroid treatment can all interact with glucose control.
This creates a potential cycle.
Respiratory illness → stress response → higher glucose → reduced activity → more difficulty controlling health conditions.
Then treatment for a severe respiratory episode may add another factor.
For example, systemic corticosteroids are often used for certain acute exacerbations because they can reduce airway inflammation. However, systemic steroids are well known to cause hyperglycemia.
That does not make steroid treatment “bad.”
It means doctors have to balance:
Respiratory benefit + metabolic risk.
For a severe asthma or COPD exacerbation, controlling the breathing problem may be the immediate priority, while blood glucose is monitored and managed alongside it.
9. Who Should Monitor Blood Sugar More Closely?
Quick answer: People with established diabetes, prediabetes, previous steroid-related hyperglycemia, or repeated courses of corticosteroids may benefit from closer glucose monitoring when their respiratory medicines change or their illness worsens. The exact monitoring plan should be individualized.
Extra attention may be useful if you:
- Have type 1 or type 2 diabetes
- Have prediabetes
- Use high-dose inhaled corticosteroids
- Frequently need oral steroids
- Are receiving repeated nebulized beta-2 agonists
- Have recently had a severe asthma or COPD exacerbation
- Notice unexplained changes in glucose readings
If your doctor starts systemic steroids, ask whether your diabetes medicines or glucose-monitoring schedule need adjustment.
For people already diagnosed with diabetes, NHS guidance recommends regular glucose monitoring when systemic steroids are prescribed because treatment may need to change temporarily.
10. What Should You Do If Your Blood Sugar Rises After Using an Inhaler?
Quick answer: Do not automatically stop your inhaler. Record the glucose reading, note which medicine you used and how often, and discuss the pattern with your doctor or pharmacist. Seek urgent medical care if you have severe breathing difficulty or symptoms of dangerously high blood glucose.**
A simple tracking approach can help:
Step 1: Record your glucose
Write down:
- Time
- Blood glucose level
- Meal timing
- Inhaler used
- Number of doses
- Other medicines taken
Step 2: Look for a pattern
One unusual reading does not prove that an inhaler caused the change.
A repeated pattern is more useful.
Step 3: Review the medication
Ask your healthcare professional:
- What are the active ingredients?
- Is it a steroid inhaler?
- Is it a beta-2 agonist?
- What is the dose?
- How often should I use it?
- Do I need glucose monitoring?
Step 4: Never abruptly stop essential asthma treatment
GINA emphasizes that people with asthma should continue prescribed inhaled corticosteroid-containing treatment rather than stopping it without medical advice, because inadequate treatment can increase the risk of worsening asthma and attacks.
11. Can Better Inhaler Technique Reduce Side Effects?
Quick answer: Correct inhaler technique helps ensure that the medicine reaches the lungs as intended and may reduce unnecessary medication deposition in the mouth and throat. It cannot completely eliminate systemic absorption, but correct technique is an important part of safe and effective inhaler use.**
Common mistakes include:
- Inhaling too quickly or slowly for the device
- Not coordinating actuation and inhalation with an MDI
- Failing to hold the breath when instructed
- Not using a spacer when appropriate
- Incorrect preparation of a dry-powder inhaler
- Taking doses more frequently than prescribed
For pressurized metered-dose inhalers containing corticosteroids, GINA notes that use with a spacer is preferred where appropriate.
Correct technique is therefore not just about better symptom control.
It is also part of responsible medicine use.
Practical tip: Ask your doctor, nurse or pharmacist to watch you use your inhaler once. Even experienced patients can develop technique errors over time.
12. Should People With Diabetes Avoid Inhaled Corticosteroids?
Quick answer: No. Diabetes is not a blanket reason to avoid inhaled corticosteroids when they are clinically indicated. For asthma especially, ICS-containing treatment is an important part of preventing severe exacerbations. The goal is to use the appropriate medicine and dose while considering individual risks.
This is where online health information can become misleading.
A headline such as “steroids raise blood sugar” may be technically true but incomplete.
For asthma, inhaled corticosteroids treat the underlying airway inflammation. GINA’s current strategy recommends ICS-containing treatment rather than relying on a short-acting beta-2 agonist alone.
For COPD, inhaled corticosteroids are used selectively based on clinical factors.
Therefore, the right question is not:
“Do steroids raise blood sugar?”
It is:
“What is the benefit and risk of this particular steroid, at this dose, for this particular patient?”
That is a much more clinically useful question.
13. When Should You Talk to Your Doctor?
Quick answer: Speak with your doctor if glucose levels repeatedly rise after starting or increasing an inhaler, if you need frequent rescue medication, if you require repeated steroid courses, or if your diabetes becomes harder to control. Never change essential respiratory treatment without professional guidance.**
Contact your healthcare professional if:
- Your glucose is repeatedly above your usual target
- You have newly developed persistent high readings
- You need your reliever much more frequently
- You are using nebulized treatment repeatedly
- You have been prescribed oral steroids
- Your asthma symptoms are worsening
- Your COPD symptoms are worsening
- You are unsure whether your inhaler contains a steroid
Seek urgent medical help for severe breathlessness, inability to speak normally because of breathlessness, bluish/grey lips or face, severe confusion, or rapidly worsening symptoms.
For people with diabetes, very high glucose accompanied by vomiting, dehydration, abdominal pain, confusion or other concerning symptoms also requires urgent medical assessment.
14. What Is the Best Way to Balance Respiratory and Blood Sugar Health?
Quick answer: The safest approach is coordinated management: control asthma or COPD effectively, use inhalers exactly as prescribed, monitor glucose when clinically appropriate, and review medication whenever treatment changes. Good respiratory control can reduce the need for emergency treatments such as repeated systemic steroids.**
Think of asthma/COPD care and diabetes care as connected—not competing goals.
A practical checklist
For respiratory health:
- Know which inhaler is your controller and which is your reliever.
- Use your prescribed dose.
- Learn correct inhaler technique.
- Attend regular reviews.
- Do not stop controller treatment without advice.
- Have an action plan for worsening symptoms.
For glucose health:
- Monitor according to your diabetes care plan.
- Record unusual readings.
- Pay attention when medicines change.
- Ask about glucose monitoring during steroid treatment.
- Report repeated unexplained hyperglycemia.
The larger goal is to reduce severe respiratory exacerbations while minimizing unnecessary systemic medication exposure.
GINA emphasizes inhaled corticosteroid-containing treatment because preventing severe asthma exacerbations is a central goal of asthma care.
15. The Bigger Picture: Don’t Blame Every Glucose Rise on Your Inhaler
Quick answer: A rise in blood glucose after using an inhaler can have several explanations. The medicine may contribute, especially with high-dose beta-2 agonists or systemic steroid exposure, but illness, stress hormones, diet, reduced activity and underlying diabetes can also play roles.**
This is particularly important during an asthma or COPD flare.
Suppose someone with diabetes has:
- Wheezing
- Poor sleep
- Reduced physical activity
- An infection
- Frequent salbutamol use
- A short course of oral steroids
Their glucose may rise substantially.
It would be inaccurate to say:
“The inhaler caused my diabetes.”
It would be more accurate to say:
“Several factors may be affecting my glucose, including my respiratory illness and medicines.”
That distinction leads to better medical decisions.
Inhalers and Blood Sugar: At-a-Glance Comparison
| Medicine/type | Main purpose | Potential glucose effect |
|---|---|---|
| Inhaled corticosteroid | Controls airway inflammation | Usually limited at standard doses; greater concern with high doses/long-term exposure |
| Salbutamol/albuterol | Quick bronchodilation | Can temporarily increase blood glucose, particularly at higher doses |
| LABA | Long-acting bronchodilation | Metabolic effects depend on drug and exposure |
| LAMA | Long-acting bronchodilation | Not primarily associated with blood glucose elevation |
| ICS/LABA combination | Anti-inflammatory + bronchodilation | Depends on both components and dose |
| Oral corticosteroid | Treats significant inflammation/exacerbations | Strong, well-established hyperglycemic effect |
The table is a general educational comparison. The exact effects depend on the specific medicine, formulation, dose and patient.
What About Inhalers in India?
For patients in India, the same basic principles apply, but brand names and inhaler combinations can vary considerably.
A patient may encounter:
- Metered-dose inhalers
- Dry-powder inhalers
- Breath-actuated devices
- Nebulized medicines
- Combination inhalers
Some products may contain multiple active ingredients.
Therefore, searching only for a brand name online is not always enough.
When discussing an inhaler with an Indian doctor or pharmacist, have the packaging or prescription available and ask:
“Does this contain a steroid or a beta-2 agonist, and could it affect my blood sugar?”
This is especially useful if you have diabetes and are starting a new inhaler or changing your respiratory treatment.
India also has a large burden of diabetes, making medication-related glucose monitoring particularly relevant for patients who have both metabolic and respiratory conditions.
However, local availability should never be used as a reason to substitute one inhaler for another without professional guidance.
Common Myths About Inhalers and Blood Sugar
Myth 1: “Every inhaler increases blood sugar.”
Fact: No. Different inhalers contain different medicines, and their metabolic effects differ.
Myth 2: “If I have diabetes, I cannot use steroid inhalers.”
Fact: Diabetes does not automatically rule out an inhaled corticosteroid when clinically indicated.
Myth 3: “Inhaled steroids are exactly the same as steroid tablets.”
Fact: They are both corticosteroids, but inhaled medicines generally produce much lower systemic exposure than oral steroids at standard doses.
Myth 4: “A high glucose reading proves the inhaler caused it.”
Fact: Illness, stress, diet, activity and other medicines can also affect glucose.
Myth 5: “I should stop my inhaler if glucose rises.”
Fact: Stopping essential respiratory treatment without medical advice can be dangerous. Discuss the glucose pattern and medication with your healthcare professional.
Frequently Asked Questions: Can Inhalers Raise Blood Sugar Levels?
Can inhalers raise blood sugar levels?
Yes, some can. High-dose beta-2 agonists such as salbutamol can cause reversible increases in blood glucose, while inhaled corticosteroids generally have less systemic effect than oral steroids. The actual effect depends on the drug, dose, frequency and individual health.
Do steroid inhalers increase blood sugar?
Usually, standard-dose inhaled corticosteroids have a much smaller effect on blood glucose than steroid tablets. However, systemic effects can increase with higher doses and prolonged use. People with diabetes may need individualized monitoring.
Can salbutamol inhalers raise blood glucose?
Yes. Salbutamol can produce reversible metabolic changes, including increased blood glucose, particularly at higher doses. People with diabetes may need closer monitoring during intensive treatment.
Can COPD inhalers cause diabetes?
Not all COPD inhalers have the same risk. Research has examined a possible association between inhaled corticosteroid use and diabetes development or worsening glycemic control, but the evidence is complicated and does not mean that every COPD patient using an ICS will develop diabetes.
Are oral steroids more likely to raise blood sugar than inhaled steroids?
Yes. Oral corticosteroids have substantially greater systemic exposure and are well known to raise blood glucose. Inhaled corticosteroids generally have less systemic effect when used at standard doses.
Should diabetics avoid asthma inhalers?
No. Diabetes does not mean that a person should avoid medically necessary asthma treatment. Effective asthma control is important, and inhaled corticosteroid-containing treatment is a key component of modern asthma management.
Should I check blood sugar after using an inhaler?
If you have diabetes and notice repeated glucose changes after starting or intensifying respiratory treatment, discuss monitoring with your healthcare professional. Monitoring may be particularly relevant during high-dose beta-2 agonist treatment or systemic steroid courses.
Can an inhaler cause permanent diabetes?
A single inhaler dose does not mean you will develop permanent diabetes. Long-term diabetes risk is more complicated and depends on factors such as genetics, weight, lifestyle, underlying metabolic health and medication exposure. Evidence linking inhaled corticosteroids to diabetes is mixed.
Can asthma itself increase blood sugar?
During illness or an asthma exacerbation, the body’s stress response can increase blood glucose. Treatment used during severe attacks can also influence glucose. Therefore, a high reading during an exacerbation does not automatically mean the inhaler caused it.
What should I do if my blood sugar is high after my inhaler?
Do not stop the inhaler on your own. Record your glucose level, the inhaler and dose used, and any other medicines you are taking. If high readings continue, contact your doctor or diabetes care team for advice.
Key Takeaways
Can inhalers raise blood sugar levels? Sometimes—but the answer depends on the inhaler.
The most important points are:
- Not all inhalers affect glucose in the same way.
- Standard-dose inhaled corticosteroids generally have less systemic glucose impact than oral steroids.
- High-dose or frequent salbutamol/beta-2 agonist treatment can temporarily increase blood glucose.
- Long-term/high-dose inhaled corticosteroid exposure deserves individualized consideration, particularly in people with diabetes.
- COPD research has identified a possible relationship between ICS exposure and diabetes, but the evidence is not simple or definitive.
- Respiratory illness itself can affect glucose control.
- Do not stop a prescribed asthma or COPD inhaler without medical advice.
- If glucose repeatedly rises after a treatment change, discuss the pattern with your doctor or pharmacist.
- Correct inhaler technique and appropriate dosing remain essential.
- For severe breathing symptoms, seek urgent medical care rather than delaying treatment because of concerns about glucose.
The best respiratory treatment is not necessarily the one with the fewest possible side effects—it is the one whose benefits and risks are appropriate for your individual health needs.
